January 31, 2015 7:30 AM ET


Company Overview of Sirna Therapeutics, Inc.

Company Overview

Sirna Therapeutics, Inc. develops therapeutics based on RNA interference (RNAi) technology. It provides research, preclinical, and/or clinical development with product candidates in various areas, including age-related macular degeneration (AMD), chronic hepatitis, dermatology, asthma, Huntington’s disease (HD), oncology, and diabetes. The company offers Sirna-027, which completed phase I clinical trial is used for the treatment of AMD; Sirna-034, which is under preclinical stage is used for the treatment of hepatitis C virus; and various drugs under preclinical stage of development for asthma, HD, chronic hepatitis, diabetes, and dermatology. It has strategic alliances with Allergan, Inc., ...

185 Berry Street

Suite 6504

San Francisco, CA 94107

United States

Founded in 1992

68 Employees





Key Executives for Sirna Therapeutics, Inc.

Chief Medical Officer and Senior Vice President of Development
Age: 59
Age: 75
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Neurolixis, Inc. United States
Primordial Genetics, Inc. United States
Vitae LLC United States
Biotage, LLC United States
Cytogel Pharma, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sirna Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.